Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -20,610 | -6,620 | -12,620 | -8,460 |
| Depreciation Amortization | 1,360 | 1,310 | 1,050 | 1,170 |
| Other Working Capital | -3,080 | 16,720 | -150 | 70 |
| Other Operating Activity | 1,480 | 410 | 940 | 1,610 |
| Operating Cash Flow | $-20,850 | $11,820 | $-10,780 | $-5,610 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -710 | -720 | -1,350 | -700 |
| Other Investing Activity | 6,330 | -34,620 | 12,780 | -8,830 |
| Investing Cash Flow | $5,620 | $-35,340 | $11,430 | $-9,530 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 17,580 | 23,650 | -3 | 15,580 |
| Financing Cash Flow | $17,580 | $23,650 | $-3 | $15,580 |
| Beginning Cash Position | 630 | 460 | -210 | -630 |
| End Cash Position | 3,000 | 590 | 430 | -190 |
| Net Cash Flow | $2,360 | $130 | $650 | $430 |
| Free Cash Flow | ||||
| Operating Cash Flow | -20,850 | 11,820 | -10,780 | -5,610 |
| Free Cash Flow | -20,850 | 11,820 | -10,780 | -5,610 |